FDA Law Blog

JANUARY 6, 2022

Wasserstein — “EKRA” refers to the Eliminating Kickbacks in Recovery Act, which was part of the Substance Use – Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018. S&G Labs is primarily compensated by patient’s insurance providers. EKRA is codified at 18 U.S.C. § EKRA Issue.

Lab Testing 52

Lab Testing Individual Referral Patient-Centered 52

FDA Law Blog

JANUARY 6, 2022

Wasserstein — “EKRA” refers to the Eliminating Kickbacks in Recovery Act, which was part of the Substance Use – Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018. S&G Labs is primarily compensated by patient’s insurance providers. EKRA is codified at 18 U.S.C. § EKRA Issue.

Lab Testing 40

Lab Testing Individual Referral Patient-Centered 40

GeriPal

FEBRUARY 27, 2025

But back in 2019, there was a lot of disagreement in our group about whether for a patient with cancer and cancer related pain and a substance use disorder, whether palliative care was the appropriate specialty to care for those patients. They’re only allowed to prescribe it for opioid use disorder, opioid cravings and Sach.

Patients 73

Patients Clinic Patient-Centered Illness 73